Aurobindo Pharma Limited has informed the Exchange regarding Closure of Buy Back with effect from May 15, 2026

Buyback Premium Above 10pctCorporate Actions View source PDF

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.2%1-day move

₹1510.30

prior close

₹1514.30

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.5+0.3-0.0-0.5+0.2+0.7+2.6-2.8-3.7-5.2-4.7-4.3+3.2—

Up moveDown movePending

AI summary

Aurobindo Pharma Limited has completed its buyback programme, extinguishing 54,23,728 equity shares (representing approximately 0.93% of pre-buyback capital) at ₹1,475 per share. The total buyback value was capped at ₹800 crore. The share capital has reduced from 58,08,01,623 shares to 57,53,77,895 shares of ₹1 face value each. The tender offer route was used, and the extinguishment was completed on May 14, 2026. Promoter holding increased marginally from 51.82% to 51.88% post-buyback.

Likely market impact

The buyback reduces the outstanding share count, which can improve per-share metrics like EPS. Offering ₹1,475 per share provided a significant premium to shareholders who participated, potentially supporting the stock price near that level.